Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Photobiomodulation therapy for thrombocytopenia by upregulating thrombopoietin expression via the ROS-dependent Src/ERK/STAT3 signaling pathway

Our research suggests that PBMT is a promising therapeutic strategy for the treatment of CIT.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors used cell and mouse experiments to study whether photobiomodulation therapy raises platelet production in chemotherapy-induced thrombocytopenia. They report that the therapy increased liver thrombopoietin expression through a reactive oxygen species-dependent Src/ERK/STAT3 pathway, and that it prevented a severe drop in platelet counts in mice. The authors describe the therapy as promising, but the abstract does not state sample sizes or clinical testing in people.

Who or what was studied
Thrombocytopenic mice and hepatic cells; the abstract does not describe human participants.
Limits stated in the abstract
The abstract reports only mouse and cell experiments, and it does not state sample sizes, light parameters or any human data.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation therapy, Reactive oxygen species, Photobiomodulation. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Other

Low-level light treatment ameliorates immune thrombocytopenia

These adverse effects of anti-CD41 antibody were all mitigated by LLLT to varying degrees, owing to its ability to enhance mitochondrial biogenesis and activity in megakaryocytes and preserve mitochondrial functions in platelets in the presence of the antibody.

Study · November 30, 2016 · Yang J et al.